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Canine monocytic ehrlichiosis (CME) is a widespread, tick-borne, canine disease, caused 
by an obligate intracellular bacterium, Ehrlichia canis. The main vector, a brown-dog tick, 
Rhipicephalus sanguineus, is widely distributed, especially in areas with tropic, subtropic, 
or Mediterranean climates (Central and South America, Eastern and Western Asia, 
Africa, Australia and Southern Europe).  The study performed in 2012, by Stefanovska 
et al., determined a seroprevalence of  18.7% of  E. canis among the Macedonian dog 
population. Up to date, the presence of  E. canis, using molecular diagnostic methods, 
has not been investigated in Macedonia. Therefore, this study aimed to confi rm the 
presence of  E. canis, in the pet-dog population on the territory of  the city of  Skopje, 
North Macedonia, using a highly sensitive multiplex Real-Time PCR method (qPCR). 
Whole blood samples from 80 dogs of  different breeds and ages, with clinical symptoms 
of  CME and positive serology result for the presence of  antibodies against E.canis, were 
collected for analyses. Out of  80 dogs, 36 (45%) were found as positive. The present 
work reports the fi rst molecular detection of  E. canis in pet dogs on the territory of  the 
city of  Skopje, Macedonia.
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INTRODUCTION 
Canine monocytic ehrlichiosis (CME) is a widespread, tick-borne, canine disease, 
caused by an obligate intracellular bacterium, Ehrlichia canis. The other two closely 
related species, Ehrlichia ewingii, and Ehrlichia chaffeensis, are known to infect dogs, as 
well, causing similar but milder clinical diseases [1]. 
The main vector of  E. canis, a brown-dog tick, Rhipicephalus sanguineus, is widely 
distributed, especially in the areas with tropic, subtropic or Mediterranean climates 
(Central and South America, Eastern and Western Asia, Africa, Australia, and Southern 
Europe) [2-4]. Besides causing the disease in dogs, E. canis has a zoonotic potential 
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and can be a cause of  human ehrlichiosis [5]. On the other hand, the epidemiological 
importance of  E. ewinvii and E. chaffeensis seems to be limited only to North America, 
because the presence of  their vectors, Amblyomma americanum and Dermacentor variabilis 
ticks, has not been reported outside this continent [6].
The infection with E. canis in dogs can be asymptomatic for months, or with the 
immediate development of  clinical signs. The incubation period can vary from eight 
to twenty days. The disease is of  multisystemic character and can be manifested as 
acute form with fever, depression, anorexia, splenomegaly, lymphadenopathy and 
hemorrhage predisposition, subclinical form with no apparent clinical signs of  the 
disease, or chronic form with symptoms similar to those in the acute form, but more 
severe [2,7]. 
Different forms of  the disease can hardly be distinguished in everyday clinical practice 
[8]. The main hematological alterations are moderate to severe thrombocytopenia, 
non-regenerative anemia, and depending on the disease stage, moderate to severe 
leucopenia [9]. 
Even though there is no perfect diagnostic test for E. canis, serological tests are most 
commonly used for the diagnosis of  E. canis infections [10]. Antibodies against 
E.canis appear 7-35 days post infection and are not in correlation with the clinical 
manifestation and the duration of  the disease [8]. Antibodies for E.canis can persist in 
the circulation for several months to years after treatment, and they cannot be used in 
the determination of  active or past infection [11]. 
Therefore, the molecular diagnostic methods are considered as the most appropriate 
for the diagnosis of  E. canis infection [12].  Polymerase chain reaction (PCR) is a very 
sensitive method for the detection of  acute monocytic ehrlichiosis in dogs, and it is 
an irreplaceable diagnostic tool, especially in the fi rst two weeks of  infection, prior to 
antibody development and the onset of  clinical signs [13]. However, the use of  PCR 
for the detection of  E. canis in the subclinical and chronic form may have limited value 
due to the low concentration of  the microorganism in the circulation, which can result 
in false-negative results [14,15].
Molecular studies conducted around the world presented E.canis prevalence of   41.59% 
in India, 28.0% in Pakistan, 29.26% in Mexico, 37.0% in the Caribbean island of  Saint 
Kitts, 34.50% in Northeastern Brazil, and  22.0% in Portugal [16-21].
Serological evidence for the presence of  CME in dogs has been reported in almost all 
Balkan countries (Greece, Albania, Serbia, and Bulgaria) [22-25]. The study performed 
in 2012, by Stefanovska et al, determined the seroprevalence of  18.7% of  E. canis 
among the Macedonian dog population [26]. However, published data on studies for 
molecular detection of  Е. Canis are reported only from Greece [27]. 
Up to date, the presence of  E. canis, using molecular diagnostic methods, has not been 
investigated in Macedonia. Therefore, this study aimed to confi rm the presence and 
determine the prevalence of  E. canis, in the pet-dog population on the territory of  
the city of  Skopje, using a highly sensitive multiplex Real-Time PCR method (qPCR).




The targeted group was pet dogs brought to the University Veterinary Clinic (UVC) 
at the Faculty of  Veterinary Medicine – Skopje (FVMS), and several other private 
veterinary clinics on the territory of  the city of  Skopje, exhibiting clinical symptoms 
characteristic for tick-borne diseases (fever, anorexia, lethargy, and pale mucosa), and 
hematological alterations with the presence of  thrombocytopenia and/or anemia. All 
dogs were screened for the presence of  antibodies against E. canis using a commercially 
available immunochromatography based point-of-care (POC) test (SNAP® 4Dx®; 
IDEXX Laboratories, Inc. U.S.A). Finally, only the seropositive animals were selected 
for further investigation and detection of  E. canis. 
From May 2018 until September 2019, 80 whole blood samples from naturally infected 
pet dogs (47 males and 33 females), of  different breeds and ages, were collected and 
analyzed using the qPCR method. Whole blood samples were collected in 3ml vacuum 
tubes sprayed with Ethylenediaminetetraacetic Acid (Vacuette, K3E K3EDTA, 
Greiner Bio-One), and stored at -20°C until DNA extraction. 
DNA extraction
Total DNA was obtained from 200µL of  whole blood, using an automated extraction 
system (SaMag-24, Sacace, Italy), and an appropriate DNA extraction kit (SaMag Blood 
DNA Extraction kit, REF SM001), according to the manufacturer’s protocol. For 
optimization of  the DNA input in the qPCR reaction, the quantity and purity of  the 
extracted DNA was evaluated for each sample, using the UV-Vis spectrophotometer 
(NanoDrop 2000C, Thermo Scientifi c), and determination of  the A 260/280 ratio. 
Detection of Ehrlichia canis by qPCR
For detection of  E. canis DNA, a highly sensitive, multiplex, Taqman-based qPCR 
protocol, previously described by Peleg et al., 2010, was used. [28] The protocol 
is designed to amplify a short sequence within the 16S rRNA of  E. canis, and 
additionally, the canine beta actin gene (ACTB) as an internal control (IC). Even 
though this protocol detects E. ewingii and E. chaffeensis, as well, аs neither the presence 
of  competent vectors nor the pathogens themselves have been confi rmed in Europe 
so far, we considered the positive amplifi cation of  the 16S rRNA fragment of  Erlichia 
genom to be specifi c for E. canis. 
Shortly, the primers used for amplifi cation of  the 16S rRNA sequence of  E. canis were: 
forward E.c 16S fwd – 5’-TCGCTATTAGATGAGCCTACGT-3’, reverse E.c 16S rev – 
5’-GAGTCTGGACCGTATCTCAGT-3’, and the probe E. canis 16S rRNA -  5’-Fam-
GTCTGAGAGGACGATCAGCCACACT-3’-BHQ1. The primers for amplifi cation of  
the ACTB were: forward Canine actin fwd- 5’- GCGCAAGTACTCTGTGTGGAT-3’, 
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revers Canine actin rev – 5’- GTCGTACTCCTGCTTGCTGAT-3’, and Canine beta 
actin pro - 5’-JUN-TCCTGGCCTCACTGTCCACCTTCCAGCA-3’-QSY. The 
primers and probes were synthesized by Applied Biosystems. Amplifi cation reaction 
was performed on QuantStudio® 5 Real-Time PCR System (Applied BiosystemsTM, Cat.no. 
A28138), using the Path-ID™ Multiplex One-Step RT-PCR Kit (Applied BiosystemsTM, 
Cat.no. 4442136). The total volume of  the reaction was 25 µl, containing: Multiplex 
RT-PCR Buffer 12.5 µl, E. canis primer-mix 2 µl (fi nal concentration of  primers and 
the probe in the mix 0.8 µM and 0.2 µM, respectively), ACTB primer-mix 2 µl (fi nal 
concentration of  primers and the probe in the mix 0.25 µM and 0.12 µM, respectively), 
Multiplex Enzyme Mix 2.5 µl, DNase/RNase free water 3 µl, and 3 µl of  template 
DNA. The thermal cycling conditions were as follows: 95°C for 10 minutes, 40 cycles 
of  95°C for 15 seconds, and 60°C for 45 seconds. The intensity of  the fl uorescence 
signal was measured at the end of  each cycle. DNase/RNase free water, as a non-
template control (NTC), and E. canis extracted DNA optimized at Ct 32 (±2), as a 
positive control, was used in each run.
Based on the internal verifi cation and determination of  the limit of  detection (LOD) 
of  the qPCR protocol, the cut-off  value for the positive result was set at < Ct 39 (data 
not presented).
RESULTS AND DISCUSSION
Eighty blood samples from pet dogs, living on the territory of  the city of  Skopje, 
were analyzed for the presence of  E. canis using the qPCR method, of  which 36 were 
found as positive, giving an overall prevalence of  45%. The prevalence of  E. canis was 
calculated as 55.6% (20 of  47) among the male dogs, and 44.4% (16 of  33) among 
the female dogs, included in this study. A chi-square test of  independence showed 
that there was no signifi cant association between gender and the prevalence of  E. 
canis, X2 (2, N = 80) = 0.275, p = .59. The obtained Cycle threshold (Ct) values, as an 
indicator of  the quantity of  the extracted E. canis DNA, ranged from 19.39 to 37.89, 
with the average value of  31.25. Of  this, 36.11% (13 of  36) of  the positive results were 
with Ct values lower than 30, and 68.89% (23 of  36) with Ct values higher than 30. 
The main hematological alterations characteristics of  CME, thrombocytopenia and 
anemia, were present in 95% (76 of  80) and 66.25% (53 of  80) of  the dogs included 
in this study, respectively. 
Unspecifi c clinical manifestation, together with the lack of  sensitive diagnostic 
procedures impairs the overall diagnosis of  CME [12]. Thus, the combination of  
clinical, serological and molecular diagnostic procedures is required for early detection 
of  circulating E. canis. Through personal communication with the major veterinary 
clinics/ambulances in Macedonia, the commercial POC tests for detection of  IgG 
antibodies against E. canis, was found to be the most commonly used tests for diagnosis 
of  CME. Even though, the presence of  E. canis has been indirectly confi rmed with 
previous serological studies [26], direct detection of  the pathogen, using molecular 
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diagnostic methods, has never been performed in Macedonia. This study presents 
the results of  the fi rst molecular survey designed for confi rmation of  the presence 
and determination of  the prevalence of  E. canis among pet-dogs, exhibiting clinical 
signs of  a tick-borne disease on the territory of  the city of  Skopje. In addition to 
clinical signs, the presence of  hematological alterations (thrombocytopenia and/
or anemia), and confi rmation of  the presence of  antibodies against E. canis, were 
used as a diagnostic approach to maximize the probability of  detecting circulating 
E. canis using the qPCR method. From the 80 seropositive pet dogs included in this 
study, in 36, successful amplifi cation of  the specifi c fragment within the 16S rRNA 
of  E. canis, was obtained. The established prevalence of  45.0%, was similar to the 
prevalence observed in molecular studies conducted in several countries from different 
continents [16-21]. However, some studies report a rather low prevalence of  E. canis 
(Malaysia – 2%, Myanmar – 0.75%, etc.), or even fail to detect the presence of  E. 
canis in the studied dog population (Croatia) [10,29,30]. The established differences 
in the prevalence of  E. canis in different studies are mainly infl uenced by the wide 
variety of  approaches used for the study design. In general, studies reporting a low 
prevalence of  E. canis mostly used a simple random sampling method of  apparently 
healthy dogs, as a method for selection, while the majority of  studies reporting higher 
prevalence used a more targeted approach selecting only dogs exhibiting clinical 
symptoms of  tick-borne disease or only seropositive dogs, such was the case with 
our study. The established high prevalence of  E. canis among pet dogs living on the 
territory of  the city of  Skopje, indicates a frequent exposure, as well as a low level or 
poor protection against ectoparasites of  this population. No signifi cant difference (p> 
0.05) was observed when comparing the prevalence on a gender level. However, the 
slightly higher prevalence observed in the male in comparison to female dogs (55.6%, 
and 44.4%, respectively), goes in line with the data from similar studies conducted in 
Portugal and Malaysia [21,10].  
In 55% (44 of  80) of  the seropositive dogs, we failed to detect circulating E. canis in 
the analyzed whole blood samples. The whole blood samples were chosen because of  
the noninvasive nature of  this sampling technique and the established suitability of  
these samples for molecular detection of  E. canis [31,32]. The reason for this is the 
ability of  the bacteria to “hide” in the spleen and other organs, in the subclinical phase 
of  the disease, while the level of  antibodies is high and the level of  circulating bacteria 
is very low (severe pancytopenia in the chronic phase) [31,33,34].
Based on the results from the study conducted by Waner et al. (2014), the sensitivity 
of  the qPCR method dramatically decreases 17 days post infection (DPI) [35]. Thus, 
only 36.11% (13 of  36) of  the confi rmed positive dogs in this study, with Ct values 
lower than 30, could be considered as being detected within 15 DPI (acute phase). The 
use of  spleen aspirates for the confi rmation of  E. canis, in seropositive/qPCR negative 
dogs, will contribute to increasing the level of  sensitivity of  the overall diagnostic 
approach, and identifi cation of  the carrier status for CME in dogs with a subclinical 
or chronic form of  the disease [15].
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Besides the presence of  clinical symptoms (fever, depression, anorexia, etc.), and 
serological confi rmation of  the antibodies against E. canis (100%), thrombocytopenia 
was the most prevalent fi nding, present in 95% (76 of  80) of  the dogs included in this 
study. This highlights the diagnostic value and signifi cance of  this parameter for the 
general approach in CME diagnostic. 
The study should be further continued with the determination of  the genetic 
characteristics of  Macedonian E. canis isolates, and the establishment of  
epidemiological relations with the closely related isolates deposited in the accessible, 
open-source, genetic databases. 
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MOLEKULARNA DETEKCIJA EHRLICHIA CANIS U 
POPULACIJI PASA -KUĆNIH LJUBIMACA U SEVERNOJ 
MAKEDONIJI
Elena ATANASKOVA PETROV, Irena CELESKA, Zagorka POPOVA,
Kiril KRSTEVSKI, Igor DJADJOVSKI
Monocitna erlihioza pasa (CME) je široko rasprostranjena bolest pasa, koja se prenosi 
krpeljima, a uzrokuje je obligatno-intracelularna bakterija Ehrlichia canis. Glavni vektor, 
smeđi krpelj pasa, Rhipicephalus sanguineus, široko je rasprostranjen, posebno u oblasti-
ma sa tropskom, subtropskom ili mediteranskom klimom (Centralna i Južna Amerika, 
Acta Veterinaria-Beograd 2021, 71 (2), 230-238
238
Istočna i Zapadna Azija, Afrika, Australija i Južna Evropa). U Studiji izvedenoj 2012. 
godine, Stefanovska i saradnici su utvrdili da među severnomakedonskom populaci-
jom pasa, seroprevalencija E. canis iznosi 18,7%. Do danas, prisustvo E. canis, koristeć i 
molekularne dijagnostičke metode, nije istraženo u Severnoj Makedoniji.
Stoga je ova studija imala za cilj da potvrdi prisustvo E. canis u populaciji kuć nih lju-
bimaca na teritoriji grada Skoplja u Severnoj Makedoniji, koristeć i visoko osetljivu 
multiplex Real-Time PCR (qPCR). Za analize su prikupljeni uzorci pune krvi od 80 pasa 
različitih rasa i uzrasta, sa kliničkim simptomima CME i pozitivnim serološkim rezul-
tatom na prisustvo antitela protiv E.canis. Od 80 pasa, 36 (45%) je ocenjeno kao pozi-
tivno. Ovaj rad izveštava o prvom molekularnom otkrivanju E. canis kod pasa kuć nih 
ljubimaca na teritoriji grada Skoplja, Severna Makedonija.
